Damian McNamara is an award-winning multimedia writer and reporter, specializing in medicine and science. With a focus on providing accurate and up-to-date information, Damian's work can be found on platforms such as Medscape, WebMD, and the University of Miami. He is particularly active in covering COVID-19 news and updates.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Damian’s coverage mainly focuses on medical research and healthcare, with a strong emphasis on citing data. He would likely be most interested in pitches that provide access to new research findings or insights backed by credible data.
Given the variety of topics Damian covers within the medical field, he may be receptive to expert commentary from researchers, physicians, and professionals who can offer evidence-based perspectives in areas such as liver health, inflammatory bowel disease, gastrointestinal cancer, COVID-19 treatments, among others.
While there is no specific geographic focus mentioned for Damian's articles, his coverage spans a wide range of scientific and healthcare topics without apparent regional limitation.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Damian Mcnamara
UHealth co-sponsored the 8th Annual Winter Technology & Innovation in Orthopedics Symposium and encouraged collaboration amongst institutions.
By: Damian Mcnamara
Miller School public health experts are using an NIH grant to train U.S. Virgin Islands undergrads in cardiovascular research.
By: Damian McNamara
ORLANDO, FLORIDA — New potential treatment strategies for people with rosacea include botulinum toxin, the antidepressant paroxetine, and a low-molecular-weight analog of heparan sulfate, according to evidence published in the last year. At the same time, there is new recognition that systemic inflammation can occur with rosacea, and targeting treatment to the phenotype continues to gain steam as a way to help people with this difficult-to-manage condition.
March 1, 2024 – You may be familiar with the basic steps: Slow down, notice what you're eating, and enjoy your food.
March 5, 2024 -- Thunderstorm asthma can strike with little warning, leaving people with the symptoms of an asthma attack during or after the dark clouds pass.
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the medication class of the moment.
March 14, 2024 – Just over 2 months into 2024, measles cases in the United States aren't looking great.
By: Damian McNamara
In the month since the large-scale cyberattack on the Change Healthcare claims clearinghouse, some clinicians have devised workarounds, applied for
Though some medical practices still struggle to restart cash flow, federal health officials and UnitedHealth Group report progress in getting clinicians back in business.
Although nowhere near the tens of thousands of cases seen in a 2022-23 outbreak, Mpox cases are up the first few months of 2024, compared to the same time last year. Here's what to know.
(833) 317-6278 
